Monthly Archives: September 2021
Targeting the gut microbiota in COVID-19: hype or hope?
Posted in News
Comments Off on Targeting the gut microbiota in COVID-19: hype or hope?
A call to arms for further randomised controlled trials in polypectomy.
Posted in News
Comments Off on A call to arms for further randomised controlled trials in polypectomy.
Defining conventional EMR in 2021: A burning issue
Posted in News
Comments Off on Defining conventional EMR in 2021: A burning issue
Proton pump inhibitor use – a risk factor for inflammatory bowel disease or an innocent bystander?
Posted in News
Comments Off on Proton pump inhibitor use – a risk factor for inflammatory bowel disease or an innocent bystander?
Bringing primary and secondary prevention into play in community prevention of gastrointestinal cancers
Posted in News
Comments Off on Bringing primary and secondary prevention into play in community prevention of gastrointestinal cancers
An Atypical Cause for a Positive Urine Pregnancy Test
Posted in News
Comments Off on An Atypical Cause for a Positive Urine Pregnancy Test
CME Exam 3: Host Genetic Determinants Associated with Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis
Posted in News
Comments Off on CME Exam 3: Host Genetic Determinants Associated with Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis
A multi-locus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer
Posted in News
Comments Off on A multi-locus blood-based assay targeting circulating tumor DNA methylation enables early detection and early relapse prediction of colorectal cancer
MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era
The model for end-stage liver disease (MELD) has been established as a reliable indicator of short-term survival in patients with end-stage liver disease. The current version (MELDNa), consisting of INR and serum bilirubin, creatinine, and sodium, has … Continue reading
Posted in News
Comments Off on MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era
Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension
Disease extent varies in ulcerative colitis (UC) from proctitis to left-sided colitis to pancolitis and is a major prognostic factor. When the extent of UC is limited there is often a sharp demarcation between macroscopically involved and uninvolved ar… Continue reading
Posted in News
Comments Off on Molecular characterization of limited ulcerative colitis reveals novel biology and predictors of disease extension